MedPath

Effect of the Consumption of a Fermented Milk Enriched With Plant Sterols (Spain)

Not Applicable
Completed
Conditions
Hypercholesterolemia
Registration Number
NCT01600820
Lead Sponsor
Danone Spain
Brief Summary

The purpose of this study is to investigate the cholesterol lowering effect of a drinkable low fat fermented milk enriched with plant sterol after 3 and 6 weeks in mildly hypercholesterolemic subjects treated or not by statins.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
126
Inclusion Criteria
  • male and female aged 18-75 years;
  • BMI between 19 and 30 kg/m2 ,
  • LDL-cholesterol higher than 130 mg/dl in individuals with a 10-year risk ≤ 20% without ischemic cardiopathy; or
  • higher than 100 mg/dl in individuals with a 10-year risk > 20% or with ischemic cardiopathy (according to NCEP ATPIII guidelines),
  • with or without statin monotherapy,
  • willing to respect the dietary advising delivered at the screening visit,
  • agreeing to a written informed consent
Exclusion Criteria
  • subject with plasma triglycerides (TG) levels > 400 mg/dL,
  • with any cardiovascular event in the last 6 months,
  • subject taking any drugs affecting lipid metabolism (including hypocholesterolemic treatment) other than statin in monotherapy,
  • diabetic (type I and type II),
  • presenting known allergy or hypersensitivity to milk proteins, soy or lactose,
  • receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters,
  • with renal failure or any other metabolic disorder which could interfere with efficacy or safety assessment of the study,
  • pregnant or breast feeding women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital de Sant Joan

🇪🇸

Reus, Spain

Hospital de Sant Joan
🇪🇸Reus, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.